bay x 1005 has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arroyo, V; Clària, J; Gaya, J; González-Périz, A; López-Parra, M; Miquel, R; Planagumà, A; Rodés, J; Titos, E | 1 |
1 other study(ies) available for bay x 1005 and Liver Dysfunction
Article | Year |
---|---|
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Carbon Tetrachloride; Carrier Proteins; Cell Count; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Models, Animal; Hepatocytes; Kupffer Cells; Leukotrienes; Lipoxins; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Matrix Metalloproteinase 2; Membrane Proteins; Quinolines; Rats; Rats, Wistar; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2 | 2005 |